The Targeted Translation Research Accelerator (TTRA) program provides an integrated research program to improve the prevention, management and treatment of diabetes and cardiovascular disease (D&CVD) and their related complications in Australia. The $47 million TTRA program is funded through the Preventative and Public Health Research initiative of the Medical Research Future Fund (MRFF) and is being delivered by MTPConnect.

Lowitja Institute was engaged to facilitate the needs assessment process for this round to determine the Indigenous-specific priority areas for research into D&CVD. In doing this, they have assessed and prioritised the related unmet health and medical needs of Aboriginal and Torres Strait Islander people in rural, remote, regional and urban Australia.